Galapagos | Costo Del Venduto



Cost Of Sales Cambiamento Data
argenx SE USD 80.8M 8.15M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Biogen USD 629.3M 45.8M 2025-03
Genmab DKK 42M 295M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
GRIFOLS EUR 1.09B 118.18M 2025-03
Hikma Pharmaceutical USD 813M 39M 2024-06
Incyte USD 67.8M 14.58M 2025-03
Merck EUR 2.32B 197M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
UCB EUR 425.5M 479.5M 2024-06
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Galapagos Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.